Skip to Content

Sodium Acetate Injection

Last Updated: January 22, 2018
Status: Current

Sodium Acetate Injection

Products Affected - Description
  • Sodium acetate injection, Pfizer
    2 mEq/mL, 20 mL vial, 25 count (NDC 00409-7299-73)

2 mEq/mL, 100 mL vial, 25 count (NDC 00409-3299-06)
Reason for the Shortage
    • American Regent has had sodium acetate on long-term back order for several years.
    • Fresenius Kabi had sodium acetate on shortage due to increased demand.
    • Pfizer has sodium acetate on shortage due to manufacturing delays.
Available Products
  • Sodium acetate injection, Fresenius Kabi
    4 mEq/mL, 100 mL vial, 25 count (NDC 63323-0032-61)

 
Sodium acetate injection, Pfizer
2 mEq/mL, 50 mL vial, 25 count (NDC 00409-3299-05)

Estimated Resupply Dates

  • Pfizer has sodium acetate 2 meq/mL 20 mL vials on back order and the company estimates a release date of late-January 2018. The 100 mL vials are available in limited supply.

Updated

January 22, 2018; December 18 and 5, November 22, September 30 and 8, August 25 and 15, July 25 and 3, June 21, 9 and 6, May 11, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide